Significance of the histologic pattern (acinar versus ductal) in the prognosis of prostatic carcinoma (English)
National licence
- New search for: de la Pena, J.J.
- New search for: Cisneros, J.
- New search for: Mora, M.
- New search for: Machuca, J.
- New search for: Martinez-Pineiro, L.
- New search for: Picazo, M.L.
- New search for: Martinez-Pineiro, J.A.
- New search for: de la Pena, J.J.
- New search for: Cisneros, J.
- New search for: Mora, M.
- New search for: Machuca, J.
- New search for: Martinez-Pineiro, L.
- New search for: Picazo, M.L.
- New search for: Martinez-Pineiro, J.A.
In:
European Journal of Cancer and Clinical Oncology
;
23
, 8
;
1236
;
1987
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Significance of the histologic pattern (acinar versus ductal) in the prognosis of prostatic carcinoma
-
Contributors:de la Pena, J.J. ( author ) / Cisneros, J. ( author ) / Mora, M. ( author ) / Machuca, J. ( author ) / Martinez-Pineiro, L. ( author ) / Picazo, M.L. ( author ) / Martinez-Pineiro, J.A. ( author )
-
Published in:European Journal of Cancer and Clinical Oncology ; 23, 8 ; 1236
-
Publisher:
-
Publication date:1987-01-01
-
Size:1 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 23, Issue 8
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1089
-
Delay in diagnosis of colorectal cancerGerard, A. / Bleiberg, H. et al. | 1986
- 1091
-
Value of CEA determination in biological fluids and tissuesSculier, J.P. / Body, J.J. / Jacobowitz, D. / Fruhling, J. et al. | 1986
- 1095
-
Perspectives in the treatment of hairy cell leukemiaDebusscher, L. / Stryckmans, P. et al. | 1986
- 1099
-
Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic diseaseBoccuzzi, Giuseppe / Brignardello, Enrico / Massobrio, Marco / Bonino, Lodovica et al. | 1987
- 1103
-
Phase I–II clinical trial with alpha-difluoromethylornithine—An inhibitor of polyamine biosynthesisHorn, Yoav / Schechter, Paul J. / Marton, Laurence J. et al. | 1987
- 1109
-
Kinetics of daunomycin in leukemia cells and leukocytes in vivo in the ratSonneveld, Pieter / Kokenberg, Esther / van der Steuijt, Koos / Nooter, Kees et al. | 1987
- 1117
-
Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cellsLamberts, Steven W.J. / Verleun, Theo et al. | 1987
- 1125
-
Relation between leukaemic cell count and degree of maturation in acute myeloid leukaemiavan der Weide, M. / Langenhuijsen, M.M.A.C. / Huijgens, P.C. / Imandt, L.M.F.M. / de Waal, F.C. / Mol, J.J. / van Rhenen, D.J. / Kester, D A.P.M. et al. | 1987
- 1131
-
Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tractJansen, R.L.H. / van der Burg, M.E.L. / Verweij, J. / Stoter, G. et al. | 1987
- 1135
-
In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)Schroyens, Wilfried A. / Dodion, Pierre F. / Sanders, Charlotte / Loos, Micheline / Dethier, Nathalie E. / Delforge, Alain R. / Stryckmans, Pierre A. / Kenis, Yvon et al. | 1987
- 1141
-
Effects of radical mastectomy on prolactin blood levels in patients with breast cancerBarni, S. / Lissoni, P. / Paolorossi, F. / Crispino, S. / Rovelli, F. / Ferri, L. / Sormani, A. / D'Alonso, U. / Bugatti, A. / Nociti, V. et al. | 1987
- 1147
-
Preclinical toxicology of platinum analogues in dogsLelieveld, Peter / van der Vijgh, Wim J.F. / van Velzen, Dic et al. | 1987
- 1155
-
A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancerSpittle, Margaret F / Hill, Bridget T / Ostrowski, M.J / Macrae, K.D / Bates, Thelma D / Martin, W.M.C / Nicol, N.T / Edelstyn, G.A et al. | 1987
- 1163
-
Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancerTueni, E.A. / Dumont, P. / Jacobovitz, D. / Atassi, G. / Rocmans, P. / Lejeune, F. / de Franquen, P. / Klastersky, J. et al. | 1987
- 1169
-
Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluidsPrice, Michael R. / Crocker, Glenn / Edwards, Susan / Nagra, Indarjit Singh / Robins, R.Adrian / Williams, Michael / Blamey, Roger W. / Swallow, Dallas M. / Baldwin, Robert W. et al. | 1987
- 1177
-
Experimental hyperthermic treatment of a human colon carcinoma xenograft. The thermal sensitivity of the tumour microcirculationvan den Berg-Blok, A.E. / Reinhold, H.S. et al. | 1987
- 1181
-
In vitro depletion of clonogenic cells in adult acute lymphoblastic leukemia with a CD10 (anti-cALLA) monoclonal antibodyMarie, Jean-Pierre / Choquet, Claudine / Perrot, Jean-Yves / Thevenin, Danielle / Pillier, Catherine / Boucheix, Claude / Zittoun, Robert et al. | 1987
- 1189
-
Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapyKent Osborne, C. / Coronado, Ester B. / Robinson, James P. et al. | 1987
- 1197
-
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trialWolf, M. / Havemann, K. / Holle, R. / Harms, V. / Drings, P. / Hans, K. / Dombrowski, H. / Victor, N. et al. | 1987
- 1207
-
Phase II evaluation of trans-N3P3Az2(NHME)4 (AZP) in non-small cell lung cancerPostmus, P.E. / Mulder, N.H. / Grampel, J.C.V.D. / Meyers, W.H. / Berendsen, H.H. et al. | 1987
- 1209
-
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumoursSmith, Geoffrey P. / Calveley, Stephen B. / Smith, Margaret J. / Baguley, Bruce C. et al. | 1987
- 1213
-
A hypothesis on the etiology of malignant melanoma: the role of chemicals interfering with melanin synthesisMorpurgo, G. / Maggini, M. et al. | 1987
- 1217
-
Implantable infusion system and thoracic venous thrombosesMorere, Jean-Francois / Boaziz, Catherine / Israel, Lucien et al. | 1987
- 1219
-
Establishment of human ovarian tumour lines in nude mice and their responses to platinum analoguesSawada, Masumi / Ozaki, Maami / Mori, Yoichi / Taniguchi, Haruo / Tateishi, Ryuhei / Wada, Akira et al. | 1987
- 1225
-
Demonstration of the hepatic uptake of radiolabelled immunotoxins using gamma scintigraphyPerkins, Alan C. / Pimm, Malcolm V. / Baldwin, Robert W. et al. | 1987
- 1231
-
Advanced prostatic cancer treated by an LH-RH agonistAlcini, E. / D'Addessi, A. / Grasso, G. / Destito, A. et al. | 1987
- 1231
-
Subjective response criteriaAaronson, N.K. et al. | 1987
- 1231
-
Identification of the three predominant prostatic-secreted proteins and their immunohistochemical localization in normal, hyperplastic and neoplastic prostatic tissueAbrahamsson, P-A. / Lilja, H. / Falkmer, S. / Wadström, L.B. et al. | 1987
- 1231
-
Clinical and endocrinological results of short term anandron treatmentAsscheman, H. / Gooren, L.J.G. / de Voogd, H.J. / Hoogslag, M.A. et al. | 1987
- 1232
-
Specificity analysis of two new mouse monoclonal antibodies reactive with prostate cancerBazinet, M. / Cote, R.J. / Fair, W.R. / Old, L.J. et al. | 1987
- 1232
-
Prostatic specific antigen (PSA) in prostatic cancerBaron, J.C. / Peyret, Ch. / Leroy, M. / Teillac, P. / Najean, Y. / Le Duc, A. et al. | 1987
- 1232
-
Results of a combined treatment in advanced prostate cancerBecker, H. / Klosterhalfen, H. et al. | 1987
- 1232
-
The treatment of metastatic prostatic cancer with the slow release LHRH analogue, “Zoladex”Beacock, C.J. / Buck, A.C. / Dealing, W.B. / Rees, R.W.M. / Griffith, K. et al. | 1987
- 1233
-
E.O.R.T.C. Genito Urinary Group trials for cancer of the prostate (1986)Bollack, C. et al. | 1987
- 1233
-
Total androgen blockade for metastatic cancer of prostateBéland, Gilles / Elhilalli, Mostafa M. / Fradet, Yves / Laroche, Bruno / Ramsey, Ernest W. / Trachtenberg, John / Venner, Peter N. et al. | 1987
- 1233
-
Long-acting (depot) D-TRP-6-LHRH(decapeptyl) in human prostate cancer. An Italian multicentric trialBoccardo, F. / Decansi, A.U. / Guerneri, D. / Martorane, G. / Giberti, C. / Cerruti, G.B. / Zenollo, A. / Germinale, T. / Usei, E. / Santi, L. et al. | 1987
- 1233
-
Endocrine effects of the pure antiandrocen anandronR in castrated patients with metastatic prostatic cancerBertagna, C. / Fiet, J. / de Géry, A. / Hucher, M. / Brisset, J.M. et al. | 1987
- 1234
-
Dihydrotestosterone measured in core biopsies from prostatic tissuesBruun, E. / Frandsen, H. / Nielsen, K. / Rasmussen, L.B. / Vinnergaard, T. / Frimodt-Møller, C. et al. | 1987
- 1234
-
In vitro study of anandronR binding to serum proteins and erythrocytes in manBree, F / N'Guyen, P. / Tremblay, D / Tillement, J.P. et al. | 1987
- 1234
-
Diganosis and staging in localized prostatic cancer with endocavitary ultrasonography: Present echotomo — graphic criteriaBono, A.V / Fava, C / Bernacchi, P / Pozzi, E / Roggia, A. et al. | 1987
- 1234
-
Decapeptyl versus pulpectomy in advanced prostate cancerBotto, H. / Richard, F. / Mathieu, F. / Camey, M. et al. | 1987
- 1235
-
A comparison of leuprolide with flutamide and leuprolide in previously untreated patients with clinical stage D2Crawford, E.D. / McLead, D. / Dorr, A. / Spoulding, J. / Benson, R. / Eisenberger, M. / Blumenstein, B. et al. | 1987
- 1235
-
Some advances in tumour markers of prostatic cancer. An help for the clinician?Daver, A. / Soret, J.Y. / Coblentz, Y. / Allain, Y.M. / Cellier, P. / Larra, F. et al. | 1987
- 1235
-
Significance of PSA; PAP in patients with or without prostatic cancerCaty, A. / Gosselin, P. / Dehaut, J.M. / Adenis, L. et al. | 1987
- 1235
-
Is the determination of bone marrow acid phosphatase a useful test in prostatic cancer?Chevreau, C. / Canal, P. / Saivin, S. / Douchez, J. / Raynal, G. / Bugat, R. / Soula, G. et al. | 1987
- 1236
-
Is prostate-specific antigen (PSA) the most useful marker for screening in prostate cancer?Delaere, K.P.J. / Van Dieijen-Visser, M.P. / Gijzen, A.H.J. / Brombacher, P.J. et al. | 1987
- 1236
-
Small cell anaplastic prostatic carcinoma associated with adenocarcinoma of the prostate: Two new cases and review of the literaturede la Pena, J.J. / Cisneros, J. / Mora, M. / Machuca, J. / Torres, A. / Martinez-Pineiro, L. / Picazo, M.L. / Martinez-Pineiro, J.A. et al. | 1987
- 1236
-
Oncogene and growth factor involvement in prostatic diseaseDavies, P. / Eaton, C.L. / Phillips, M.E.A. et al. | 1987
- 1236
-
Significance of the histologic pattern (acinar versus ductal) in the prognosis of prostatic carcinomade la Pena, J.J. / Cisneros, J. / Mora, M. / Machuca, J. / Martinez-Pineiro, L. / Picazo, M.L. / Martinez-Pineiro, J.A. et al. | 1987
- 1237
-
Prostatic cancer: Prognostic value of the histopathological pattern according to different categories (Gaeta, Gleason Grade and UICC)de la Pena, J.J. / Cisneros, J. / Mora, M. / Machuca, J. / Martinez-Pineiro, L. / Picazo, M.L. / Martinez-Pineiro, J.A. et al. | 1987
- 1237
-
Establishment of monoclonal antibody to human androgen receptor and its clinical application for protatic cancersDemura, T. / Kuzumaki, N. / Oda, A. / Asano, Y. / Takayama, N. / Koyanagi, T. et al. | 1987
- 1237
-
Effect of dihydrotestosterone (dHT)+ estradiol (E2+) dHT + prolactin (PRL) combinations on the cell proliferation of human prostatic adenomasde Launoit, Y. / Kiss, R. / Langlet, G. / De Backer, E. / Peridaens, R. et al. | 1987
- 1237
-
Cellular DNA content and proliferative index as markers in human prostate cancerDe Vita, R. / Forte, D. / Maggi, F. / Tenaglia, R. / Di Silverio, F. et al. | 1987
- 1238
-
A phase II trial of chemotherapy (CT) with fluorouracil (F), doxorubicin (A) and cis platin (P) in advanced prostatic cancer (APC)Droz, J.P. / Lupera, H. / Piot, G. / Laplaige, P. / Ghosn, M. / Théodore, C. et al. | 1987
- 1238
-
On optimation of reference values for prognostic markersEkman, P. / Lewenhaupt, A. / Eneroth, P. / Kallner, A. et al. | 1987
- 1238
-
Pharmakinetics study in man of D-Trp-6-LHRH (decapeptyl, Ipsen-Biotech) administered as slow release microspheresDrieu, K. / Devisague, J. / Dray, F. / Ezan, E. et al. | 1987
- 1238
-
Prostate cancer. Old questions and some modern aspects of histology and immunohistochemistryDhom, G. / Seitz, G. / Wernert, N. et al. | 1987
- 1239
-
Buserelin and flutamide versus subcapsular orchiectomy and flutamide in stage C and D prostatic cancer: A cost benefit ratio analysisFranzini, A. / Alfano, G. / Antolini, C. / Borghi, C.M. / Cicchetti, F. / Viganò, P. et al. | 1987
- 1239
-
Serum testosterone at baseline relates to performance status in patients with advanced prostate cancerEmtage, L.A. / Trethowan, C. / Holder, G. / Blackledge, G.R.P. et al. | 1987
- 1239
-
A randomized trial comparing zoladex 3.6 mg depot with stilboestrol 3mg/day in advanced prostate cancer: Patient characteristics, response and treatment failuresEmtage, L.A. / Trethowan, C. / Hilton, C. / Arkell, D.G. / Wallace, D..A. / Hughes, M.A. / Farrar, D.J. / Young, C. / Jones, M. / Hay, A.M. et al. | 1987
- 1239
-
Systematical association of PAP and PSA serum determination to bone scintigraphy in 283 prostate cancerFincker, F. / Sauvan, R. / Pasquier, J. et al. | 1987
- 1240
-
PSA: Management of 500 prostatic patientsGuillet, J / Role, C. / Trinh Duc, A. / Francois, H. et al. | 1987
- 1240
-
Serum osteocalcin concentration in patients with prostatic carcinomaFrancini, G. / Bigazzi, S. / Leone, V. / Gennari, C. et al. | 1987
- 1240
-
Chemotherapy of advanced prostatic cancer with epirubicinFrancini, G. / Nami, R. / Bianchini, C. / Gennari, C. et al. | 1987
- 1240
-
Latent and clinically manifest prostatic carcinomaHayashi, T. / Kiriyama, T. et al. | 1987
- 1241
-
Pain and performance status during initial treatment of prostatic cancer (PC) with a GNRH agonist: Comparison with desHoffman, P.G. et al. | 1987
- 1241
-
Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostateJohansson, J-E / Andersson, S-O / Beckman, K-W / Zador, G et al. | 1987
- 1241
-
EORTC phase II chemotherapy studies in prostate cancerJones, W.G. et al. | 1987
- 1241
-
Zoladex treatment of symptomatic prostatic carcinomaHoldeway, I.M. / Ibbertson, H.K. / Croxson, M.S. / Harvey, V. / Boulton, J. / Knox, B. et al. | 1987
- 1242
-
Endogenous androgens, adrenal androgen precursors, and their metabolism in primary tumors and lymph node metastases of human prostatic cancerKlein, H. / Bressel, M. / Kastendlek, H. / Voigt, K.D. et al. | 1987
- 1242
-
A randomized, comparative study of buserelin with des/orchiectomy in the treatment stage D2 prostatic cancer patientsKlioze, S.S. / Miller, M.F. / Spiro, T.P. et al. | 1987
- 1242
-
LH-RH agonist, zoladex (goserelin) depot formulation in the treatment of prostatic cancer. Randomized dise-finding trial in JapanKotake, T. / Usami, M. / Sonoda, T. / Matsuda, M / Okajima, E / Osafune, M / Isurugi, K / Ikaza, H / Saitoh, Y et al. | 1987
- 1242
-
In vitro effect of dihydrotestosterone (dHT), estradiol (E2), progesterone (Pg) and prolactin (PRL) on cell proliferation of human prostatic cancersKiss, R. / de Launoit, Y. / Lenglet, G. / Paridaens, R. / De Backer, E. et al. | 1987
- 1243
-
Clinical results of farlutal application in cases of advanced prostate carcinomaKoumanov, H. / Tzvetkov, M. / Mladenov, D. / Filev, A. et al. | 1987
- 1243
-
Morphological investigation as an objective criterion for evaluating the effect of treatment for advanced prostate cancerKoumanov, H. / Tzvetkov, M. / Topov, Y. / Mladenov, D. et al. | 1987
- 1243
-
Androgen receptors and molecular markers for gene expression and repression in the prostateLiao, S. / Hiipakka, R.A. / Chang, C. et al. | 1987
- 1243
-
Combining the antiandrogen anandronR with LHRH agonist; Sequential assays of hormones and prostate markers during a double-blind studyKuhn, J.M. / Bertagna, C. / Billebaud, T. / Costa, P. / Dahan, R. / Edelstein, R. / Fiet, J. / Grise, P. / Louis, J.L. / Moulonguet, A. et al. | 1987
- 1244
-
Simultaneous administration of an luteinizing hormone release hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancerMahler, C. / Denis, L. et al. | 1987
- 1244
-
Studies on a novel antiandrogen: ICI 176334Mainwaring, W.I.P. / Furr, B.J.A. / Freeman, S.N. et al. | 1987
- 1244
-
Effects of flutamide alone and flutamide plus orchiectomy on prostatic size and male sex hormones in patients with prostatic carcinomaMandressi, A. / Longo, G. / Trinchieri, A. / Coppi, F. / Dormia, G. / Pisani, E. / Granata, P. et al. | 1987
- 1244
-
Treatment of advanced prostate cancer with buserelin (HOE 766): A pilot studyMaffezzini, M. / Broglia, L. / Ronchi, F. / Colombo, R. / Rigatti, P. et al. | 1987
- 1245
-
Phase II trial of D-Trp-6-LH-RH (sustained releasing formulation) in advanced prostatic cancerMathé, G. / Keiling, R. / Gastiaburu, J. / Prévot, G. / Vannetzel, J.M. / Despax, R. / Jasmin, C. / Lévi, F. / Musset, M. / Ribaud, P. et al. | 1987
- 1245
-
Metastasis and hormone sensitivityMartin, P.M. et al. | 1987
- 1245
-
Zoladex: Endocrine effects, efficacy and safety in advanced prostate cancer. A French cooperative studyMetz, R. / Namer, M. / Adenis, L. / Audhuy, B. / Bugat, R. / Colombel, P. / Couette, J. / Grise, P. / Khater, R. / LePorz, B. et al. | 1987
- 1245
-
The role of premalignant lesions in the development of prostatic adenocarcinomaM.D. McNeal, J.A. et al. | 1987
- 1246
-
Interaction with the androgen receptor and anti-androgen activity of anandron in the prostate of different speciesMoguilewsky, M. / Cotard, M. et al. | 1987
- 1246
-
Anandron potentiates the castrating effect of the LHRH analog buserelin in the ratMoguilewsky, M. / Tournemine, C. et al. | 1987
- 1246
-
Orchiectomy associated with anandron (RU23, 908) or placebo in treatment of stage D prostate cancer: Preliminary resultsof a randomized, double-blind french cooperative studyNamer, M. / Toubol, J. / Adenis, L. / Amiel, J. / Couette, J. / Douchez, J. / Droz, J.P. / Fargeot, P. / Kerbrat, P. / Mangin, P. et al. | 1987
- 1246
-
Cancer of the prostate — is there a need for aggressive treatment?Moskovitz, B. / Levin, D.R. et al. | 1987
- 1247
-
Sustained suppression of pituitary and testicular function by controlled release injectable nafarelinPavlou, S.N. / Hoffman, P.G. / Wakefield, G.B. / LePage, M.E. / Kushinsky, S. / Kovacs, W.J. et al. | 1987
- 1247
-
PSA assays in prostate cancerPons, D. / Ramaioli, A. / Namer, M. / Galland, A. / Krebs, B.P. et al. | 1987
- 1247
-
Medical vs surgical orchiectomy in advanced prostatic cancerParmar, H. / Phillips, R.H. / Edwards, L. / Schally, A.V. / Lightman, S.L. et al. | 1987
- 1247
-
U.K. trials fortreatment of M1 prostatic cancerPeeling, W.B. et al. | 1987
- 1248
-
Radical prostatectomy: Report on 30 casesPontonnier, F. / Toualalen, A. / Plante, P. / Bernstein, J. / Benchetrit, J. et al. | 1987
- 1248
-
Relationship of androgen receptors to growth and regression of the prostateRenni, P.S. / Bruchovsky, N. / Goldenburg, L. et al. | 1987
- 1248
-
Renewal timing of long acting depot LH-RH agonist preparation (Zoladex) is critical for a maximal effectRao, B.R. / de Voogt, H.J. / Geldof, A.A. et al. | 1987
- 1248
-
Prostatic acid phosphatase in advanced prostatic cancer (M1)Rasmussen, L.B. / Brunn, E. / Juul-Jorgensen, B. et al. | 1987
- 1249
-
Cyproterone acetate therapy in the treatment of prostatic carcinoma: Personal experience with 193 patients since January 1981Suhler, A. / Masson, J.C. et al. | 1987
- 1249
-
Objective response criteria for clinical trials of treatment of carcinoma of the prostateRobinson, M.R.G. / Newling, D.W.W. et al. | 1987
- 1249
-
Current results of neutron therapy for locally advanced prostatic adenocarcinomas (stage C) at the UCL-Cliniques St-Luc (Brussels)Richard, F. / Breteau, N. / Renard, L. / Wambersie, A. et al. | 1987
- 1249
-
Single drug polyestradiol phosphate (PEP) therapy in prostatic cancer (CAP)Stege, R. / Carlström, K. / Collste, L. / Eriksson, A. / Henriksson, P. et al. | 1987
- 1250
-
Pharmacological activity of four metabolites of anandronRTournemine, C / Coussediere, D. / Cousty, C. / Tremblay, D. / Pottier, J. et al. | 1987
- 1250
-
Plasma kinetics of anandronR in the rat, dog, and patientTremblay, D / Pendyala, L / Coussediere, D. / Pouttier, J et al. | 1987
- 1250
-
Clinical effects of ketoconazole on hormone independent prostatic cancerTrachtenberg, J. / Eichenberger, T. et al. | 1987
- 1250
-
Plasma concentrations (PC) of anandronR in patients during long term therapyTremblay, D. / de Gery, A. / Mouren, M. / Pottier, J. et al. | 1987
- 1251
-
Comparison of prostate specific antigen and prostatic acid phosphatase in the management of prostatic cancerTurkes, A. / Nott, P.J. / Turkes, A.O. / Griffiths, K. et al. | 1987
- 1251
-
Transplantable human prostatic carcinoma (PC-82)_ in athymic nude mice: A model to study androgen regulated tumor growthvan Steenbrugge, G.J. / Schröder, F.H. et al. | 1987
- 1251
-
The pharmaoclogical and endocrine assessment of three different anti-androgen regimens combined with a very long acting gonadrotopin releasing hormonal analogueWaxman, J.H. / Williams, G. / Abel, P. / Farah, N. / Timmony, A. / Hewitt, G. / O'Donoghue, E.P.N. et al. | 1987
- 1251
-
Comprehensive immunohistochemical investigations of the prostate and prostate carcinomasWernert, N. / Seitz, G. / Dhom, G. et al. | 1987
- 1252
-
Clinical study of LHRH (ICI 118.630-Zoladex) in the treatment of prostatic cancerMauriac, L. / Coste, Ph. / Richaud, P. / Lamarche, Ph. / Mage, Ph. / Bonichon, F. et al. | 1987
- 1252
-
Treatment of stage D hormone resistant carcinoma of the prostate with adriamycin, VM26, cyclophosphamide & 5 FU associated with desGarcia-Giralt, E. / Guinet, F. / Auvert, J. / Pouillart, P. / Abbou, C. / Delgado, M. et al. | 1987
- 1253
-
Announcements| 1987
- 1255
-
Books received| 1987
- 1256
-
Erratum| 1987